Video

Ian Manners: Addressing Financial Toxicity for Patients

Vivor has a provider-facing technology platform that empowers providers to address financial toxicity by proactively identifying financial resources for their patients, said Ian Manner, MBA, co-founder, CEO, Vivor.

Vivor has a provider-facing technology platform that empowers providers to address financial toxicity by proactively identifying financial resources for their patients, said Ian Manners, MBA, co-founder, CEO, Vivor.

Transcript (slightly modified)

At Vivor, we make a provider-facing technology platform that really empowers providers to address financial toxicity by proactively identifying financial resources for their patients. So many patients out there, even though they have insurance, end up with a really unaffordable out-of-pocket cost; it could be a deductible, co-insurance, and so on. But, there’s a lot of resources out there that often go underused from pharmaceutical companies and from non-profit foundations. What Vivor’s done is we made it very easy for providers to match patients up with exactly the right set of resources without doing any research or any work. We integrate with their EHR, and so it really gives providers a very effective tool in their tool box to say, “We’re looking for solutions for financial toxicity, and we’re going to get you enrolled in these resources without you even having to think about it.”

Related Videos
Screenshot of an interview with Nadine Barrett, PhD
Milind Desai, MD
Masanori Aikawa, MD
Neil Goldfarb, GPBCH
Mabel Mardones, MD.
Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah.
Alexander Mathioudakis, MD, PhD, clinical lecturer in respiratory medicine at The University of Manchester
Screenshot of an interview with Ruben Mesa, MD
Ruben Mesa, MD
Screenshot of Susan Wescott, RPh, MBA
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo